These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2428694)

  • 41. Acne resolution rates: results of a single-blind, randomized, controlled, parallel phase III trial with EE/CMA (Belara) and EE/LNG (Microgynon).
    Worret I; Arp W; Zahradnik HP; Andreas JO; Binder N
    Dermatology; 2001; 203(1):38-44. PubMed ID: 11549798
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Contraception in androgenised women with a low-dose cyproterone-acetate containing one-phase preparation (author's transl)].
    Moltz L; Meckies J; Hammerstein J
    Dtsch Med Wochenschr; 1979 Sep; 104(39):1376-82. PubMed ID: 157869
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [A new ovulation inhibitor antiandrogen].
    Millet-part A; Blanes-espi A; Ferrer-barriendos J; Siqueira L; Acosta E
    J Bras Ginecol; 1984 Mar; 94(3):91-7. PubMed ID: 12266391
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hyperandrogenic women treated with a continuous-regimen oral contraceptive.
    Caruso S; Cianci S; Malandrino C; Cicero C; Lo Presti L; Cianci A
    Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):307-10. PubMed ID: 24183349
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum total and unbound testosterone and sex hormone binding globulin (SHBG) in female acne patients treated with two different oral contraceptives.
    Palatsi R; Hirvensalo E; Liukko P; Malmiharju T; Mattila L; Riihiluoma P; Ylöstalo P
    Acta Derm Venereol; 1984; 64(6):517-23. PubMed ID: 6084924
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Anti-androgen treatment of acne (author's transl)].
    Fanta D; Schneider WH; Spona J; Neufeld T
    Wien Klin Wochenschr; 1977 Sep; 89(18):622-7. PubMed ID: 143797
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of administration and withdrawal of oral contraceptive pills on serum lipids and lipoproteins.
    Arora S; Arora RC; Garg RK; Agarwal N; Nautiyal A
    Indian J Physiol Pharmacol; 1988; 32(1):67-71. PubMed ID: 3169963
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Contraceptives, application and side effects from the dermatological viewpoint].
    Schäfer I
    Dtsch Gesundheitsw; 1971 Feb; 26(9):405-9. PubMed ID: 4104204
    [No Abstract]   [Full Text] [Related]  

  • 50. [Therapy of androgenization symptoms: double blind study of an antiandrogen preparation (SH B 209 AB) against neogynon (author's transl)].
    Lachnit-Fixson U; Kaufmann J
    Med Klin; 1977 Nov; 72(45):1922-6. PubMed ID: 144842
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Anti-androgen therapy in the female].
    Schindler AE
    Geburtshilfe Frauenheilkd; 1990 Oct; 50(10):749-53. PubMed ID: 1704865
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Treatment of acne, hirsutism and alopecia, by cyproterone acetate and ethinyl estradiol].
    Neale C; Krebs D; Bettendorf G
    Acta Endocrinol Suppl (Copenh); 1971; 152():13. PubMed ID: 4251532
    [No Abstract]   [Full Text] [Related]  

  • 53. [Antiandrogen therapy of acne, falling hair and hirsutism (author's transl)].
    Kaiser E
    MMW Munch Med Wochenschr; 1980 Jun; 122(26):975-80. PubMed ID: 6158681
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Progestogens with antiandrogenic properties.
    Raudrant D; Rabe T
    Drugs; 2003; 63(5):463-92. PubMed ID: 12600226
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Proceedings: Antiandrogens].
    Hammerstein J
    Arch Gynakol; 1973 Sep; 214(1):243-7. PubMed ID: 4130934
    [No Abstract]   [Full Text] [Related]  

  • 56. The development and evaluation of an ovulation inhibitor (DIAne) containing an antiandrogen.
    Lachnit-Fixson U
    Acta Obstet Gynecol Scand Suppl; 1979; 88():33-42. PubMed ID: 160741
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Principles of hormonal contraception].
    Hammerstein J
    Arch Dermatol Forsch; 1972; 244():478-90. PubMed ID: 4119339
    [No Abstract]   [Full Text] [Related]  

  • 58. Ethinylestradiol/Chlormadinone acetate for use in dermatological disorders.
    Gómez Vázquez M; Navarra Amayuelas R; Lamarca M; Baquedano L; Romero Ruiz S; Vilar-Checa E; Iniesta MD
    Am J Clin Dermatol; 2011 Sep; 12 Suppl 1(Suppl 1):13-9. PubMed ID: 21895045
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effect and side-effect of cyproteron-acetat-treatment (author's transl)].
    Braendle W; Boess H; Breckwoldt M; Leven C; Bettendorf G
    Arch Gynakol; 1974 Jul; 216(4):335-45. PubMed ID: 4277171
    [No Abstract]   [Full Text] [Related]  

  • 60. Ethinylestradiol/Chlormadinone acetate: dermatological benefits.
    Guerra-Tapia A; Sancho Pérez B
    Am J Clin Dermatol; 2011 Sep; 12 Suppl 1(Suppl 1):3-11. PubMed ID: 21895044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.